Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Ciwujia Granules for Depression (Heart-Spleen Deficiency Syndrome)
NCT07085143Phase 4Active, not recruiting
- Sponsor
- Shanghai Mental Health Center
- Start
- Oct 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eleuthero in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Started Oct 2025; status: active, not recruiting.
02
Drugs
eleuthero
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07085143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07085143.